Douglass (Chang Hun) Lee

Humanoid robots for mission critical applications

Were on a mission to simplify health plan administration from the ground up, starting with claims processing as a third-party administrator (TPA) for Plan Designers who create employer health insurance plans. If you want to be a part of building the tools to make healthcare simpler, check out our open positions at yuzu.health/careers.

Building quantitative super-intelligence. We are hiring: careers@axiommath.ai

Everything our civilization depends on is either mined, dug, or grown. AIM transforms heavy machines into AI-powered fleets that turbocharge earthmoving. AIM’s platform has been running autonomous mines, construction sites, and building infrastructure around the world. Powered by physical AI, the AIM solution transforms bulldozers, loaders, excavators into autonomous fleets. From resource extraction to critical infrastructure, the global economy is reliant on the efficient movement of earth. Safe autonomous earthmoving is the linchpin of our civilization. AIM runs large-scale earthworks and defense operations as a TRL9 hardened system, not a science experiment. Built by engineers with deep expertise in mining, construction and AI tech, AIM enables scalable earthmoving, turbocharging the global economy’s physical foundation. AIM is backed by some of the most sophisticated capital in the world, including General Catalyst, Khosla Ventures, Elad Gil, Human Capital, Ironspring Ventures, Mantis, DCVC.

Orum Therapeutics (KRX: 475830) is a public biotechnology company developing TPD2®, a novel class of targeted protein degradation therapeutics. Also known as degrader-antibody conjugates (DACs), these therapeutics combine the precision of antibodies with Orums novel degrader payloads to break down disease-causing proteins inside specific cells. By enabling the selective degradation of previously “undruggable” targets, Orum is working to improve the effectiveness, safety, and reach of targeted protein degradation. The company’s lead programs target GSPT1, and it is also advancing next-generation payloads to expand the potential of its DAC pipeline. In parallel, Orum is developing proprietary linker technologies to increase the flexibility and precision of future DAC programs. With headquarters in Daejeon, South Korea, and Lexington, Massachusetts, U.S., Orum is globally positioned to deliver first-in-class cancer therapies for patients with hard-to-treat diseases. For more information, visit www.orumrx.com.

Valinor is a new type of defense and government tech company focused on solving the problems others don’t. Our unique model of centralized go-to-market and decentralized engineering allows us to move with unparalleled efficiency to identify unmet needs, build right-sized solutions, and get products where they matter most - in the hands of users.

Clutch is Canada’s largest online used car retailer, delivering a seamless, hassle-free car buying and financing experience to drivers everywhere. Shop thousands of used cars online, get the right one delivered to your door, and enjoy peace of mind with our 10-day Money-Back Guarantee. You can even sell or trade in your car and get an instant cash offer. How sweet is that? Clutch. Cars done right.

Lumilens addresses the red hot market for AI data center infrastructure by designing, manufacturing and selling photonic interconnect solutions. We design and use custom robotics + AI in our factories to more efficiently build our products. Lumilens is backed by top-tier venture capital investors including Mayfield and Spark Capital.

Cambium is a leader in advanced material innovation for high-performance sectors, redefining how materials are discovered and delivered. Our proprietary materials platform combines Al-driven molecular design with state-of-the-art chemistry, materials science, biology, and manufacturing capabilities. Our fully owned SHD Advanced Composites business operates five rapid-response manufacturing facilities across the U.S., U.K., and EU. This unique vertical integration of customer-led rapid innovation and rapid manufacturing allows us to move customers from concept to full-scale qualified production with exceptional speed. Our 200+ team proudly serves hundreds of customers across the aerospace, defense, energy, motorsport, marine and other high-performance industries, providing a unique materials development and manufacturing capability to accelerate their development cycles. Please visit cambium-usa.com.

ON is a leading AI chat platform designed for enterprise-level use, known for seamlessly powering generative AI experiences used by some of the worlds largest and most well-known brands.

2015년 1월에 창립한 저희는 Open Source 기반의 다양한 솔루션을 개발하고 구축하고 있습니다. 특히, 기업용 및 미디어에 특화된 솔루션을 시작으로 산업분야까지 클라우드 환경 중심의 다양한 포털서비스 및 데이터 시각화 플랫폼을 구축 공급하고 있습니다. 사용자 중심의 최적의 서비스 솔루션을 Moto로 오늘도 케이비시스는 다양한 서비스를 개발하고 있습니다.

IntraVital Microscopy is a technique that enables you to directly observe the movement of live cells that make up living tissue in vivo. With this technique, it is possible to distinguish an individual cell among a large number of cells in various organs, which is not possible with conventional biomedical imaging technologies such as MRI or CT, and to track the movement of each cell in three dimensions in real-time. It is also possible to simultaneously image living cells in living organs, surrounding microenvironments, and molecules such as proteins which is impossible with conventional tissue analysis technology. Furthermore, this enables us to analyze the in vivo efficacy of new biopharmaceuticals such as immunological, cell, gene, and antibody therapeutic agents acting in real living organisms at the cellular level which is the basic structural and functional unit of life. The worlds first All-in-One microscopy (IVM) platform developed by IVIM Technology explores the interactions among numerous cells inside the living organisms and will be the next generation high-tech imaging equipment to elucidate the complex processes of human diseases.

ImpriMed, founded in 2017 in Silicon Valley, is a leading precision medicine startup revolutionizing cancer treatment with artificial intelligence. The company’s pioneering drug response prediction technology helps reduce costs, accelerate treatment, enhance efficacy, and improve the quality of life for patients. To date, the company’s technology has been deployed across more than 40 U.S. states, and 22,000+ canine and feline blood cancer tests have been performed as of 2025. ImpriMed is now poised to extend its groundbreaking AI-driven approach to human healthcare, redefining the future of oncology treatment with personalized, effective solutions. For additional information, visit www.imprimedicine.com.

Dtonics core technology, data processing acceleration technology "Geo-Hiker™", enables big data systems to treat spatio-temporal data faster (up to 40x) and more efficiently (up to 90% processing cost reduction). Geo-Hiker™ powers Dtonics suite of Data Intelligence Platform Solutions that cater to various future industries from Smart City to Smart Retail.

Gridwiz is a clean energy startup that provides intelligent platform solutions aggregating gigawatt-scaled DERs, including DR, energy storage, renewable energy, and EV charging. Our clean and sustainable energy solutions are at the core of delivering benefits to our 1000+ customers, providing flexibility to the grid, and healing the Earth.

Humanoid robots for mission critical applications

Were on a mission to simplify health plan administration from the ground up, starting with claims processing as a third-party administrator (TPA) for Plan Designers who create employer health insurance plans. If you want to be a part of building the tools to make healthcare simpler, check out our open positions at yuzu.health/careers.

Building quantitative super-intelligence. We are hiring: careers@axiommath.ai

Everything our civilization depends on is either mined, dug, or grown. AIM transforms heavy machines into AI-powered fleets that turbocharge earthmoving. AIM’s platform has been running autonomous mines, construction sites, and building infrastructure around the world. Powered by physical AI, the AIM solution transforms bulldozers, loaders, excavators into autonomous fleets. From resource extraction to critical infrastructure, the global economy is reliant on the efficient movement of earth. Safe autonomous earthmoving is the linchpin of our civilization. AIM runs large-scale earthworks and defense operations as a TRL9 hardened system, not a science experiment. Built by engineers with deep expertise in mining, construction and AI tech, AIM enables scalable earthmoving, turbocharging the global economy’s physical foundation. AIM is backed by some of the most sophisticated capital in the world, including General Catalyst, Khosla Ventures, Elad Gil, Human Capital, Ironspring Ventures, Mantis, DCVC.

Orum Therapeutics (KRX: 475830) is a public biotechnology company developing TPD2®, a novel class of targeted protein degradation therapeutics. Also known as degrader-antibody conjugates (DACs), these therapeutics combine the precision of antibodies with Orums novel degrader payloads to break down disease-causing proteins inside specific cells. By enabling the selective degradation of previously “undruggable” targets, Orum is working to improve the effectiveness, safety, and reach of targeted protein degradation. The company’s lead programs target GSPT1, and it is also advancing next-generation payloads to expand the potential of its DAC pipeline. In parallel, Orum is developing proprietary linker technologies to increase the flexibility and precision of future DAC programs. With headquarters in Daejeon, South Korea, and Lexington, Massachusetts, U.S., Orum is globally positioned to deliver first-in-class cancer therapies for patients with hard-to-treat diseases. For more information, visit www.orumrx.com.